DexLeChem Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.72K

  • Investors
  • 2

DexLeChem General Information

Description

Provider of green development services intended for the chemical and pharmaceutical industry. The company enables the production of chiral substances with water based processes where the unmodified homogeneous catalyst can repeatedly be re-used, enabling clients to reduce pollution and cut the cost.

Contact Information

Website
dexlechem.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Chemicals and Gases
Environmental Services (B2B)
Corporate Office
  • Köpenicker Straße 325
  • Haus 11-12
  • 12555 Berlin
  • Germany
+49 0177 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DexLeChem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 15-Jul-2014 $2.72K Completed Startup
1. Accelerator/Incubator 18-Apr-2013 Completed Startup
To view DexLeChem’s complete valuation and funding history, request access »

DexLeChem Patents

DexLeChem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160355454-A1 Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions Active 06-Mar-2013 00000000000 0
US-9433937-B2 Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions Active 06-Mar-2013 00000000000 0
US-20160008803-A1 Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions Active 06-Mar-2013 0000000000
US-9758457-B2 Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions Active 06-Mar-2013 00000000000 0
ES-2614243-T3 Process for the reduction of nitro derivatives to amines Active 06-Sep-2012 C07C209/325
To view DexLeChem’s complete patent history, request access »

DexLeChem Executive Team (5)

Name Title Board Seat Contact Info
Sonja Jost Co-Founder & Chief Executive Officer
Mathis Gruber Ph.D Co-Founder & Head of Theoretical Modeling
Fabian Spittank Co-Founder
You’re viewing 3 of 5 executive team members. Get the full list »

DexLeChem Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Science4Life Accelerator/Incubator 000 0000 000000 0
EIT Climate-KIC Accelerator/Incubator 000 0000 000000 0
To view DexLeChem’s complete investors history, request access »

DexLeChem FAQs

  • When was DexLeChem founded?

    DexLeChem was founded in 2011.

  • Who is the founder of DexLeChem?

    Sonja Jost, Martin Rahmel, Regina Böttcher, Mathis Gruber Ph.D, and Fabian Spittank are the founders of DexLeChem.

  • Who is the CEO of DexLeChem?

    Sonja Jost is the CEO of DexLeChem.

  • Where is DexLeChem headquartered?

    DexLeChem is headquartered in Berlin, Germany.

  • What industry is DexLeChem in?

    DexLeChem’s primary industry is Pharmaceuticals.

  • Is DexLeChem a private or public company?

    DexLeChem is a Private company.

  • What is DexLeChem’s current revenue?

    The current revenue for DexLeChem is 00000.

  • Who are DexLeChem’s investors?

    Science4Life and EIT Climate-KIC have invested in DexLeChem.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »